Le Lézard
Classified in: Covid-19 virus
Subject: Event

PennyMac Mortgage Investment Trust Announces Date for 2020 Annual Meeting of Shareholders


PennyMac Mortgage Investment Trust (NYSE: PMT) today announced that it will hold its 2020 Annual Meeting of Shareholders at 11:00 a.m. Pacific Time on Thursday, May 14, 2020, at the Company's headquarters located at 3043 Townsgate Road, Westlake Village, CA 91361. Shareholders of record as of the close of business on March 16, 2020 are entitled to receive notice of, to attend, and to vote at the annual meeting.

We intend to hold our Annual Meeting in person. However, we are monitoring developments regarding coronavirus disease 2019 (COVID-19) and are planning for the possibility that the Annual Meeting may be held solely by means of remote communication. If we take this step, we will issue a press release announcing such change in advance, file the announcement with the Securities and Exchange Commission as additional proxy material, and will provide details on how to access and participate in and vote at the Annual Meeting at www.proxyvote.com or on our Investor Relations website at www.pennymac-reit.com/2020AnnMtg.

About PennyMac Mortgage Investment Trust

PennyMac Mortgage Investment Trust is a mortgage real estate investment trust (REIT) that invests primarily in residential mortgage loans and mortgage-related assets. PMT is externally managed by PNMAC Capital Management, LLC, a wholly-owned subsidiary of PennyMac Financial Services, Inc. (NYSE: PFSI). Additional information about PennyMac Mortgage Investment Trust is available at www.PennyMac-REIT.com.


These press releases may also interest you

at 07:00
DEADLINE ACTION NOTICE: The Schall Law Firm Encourages Investors in QuidelOrtho Corporation with Losses to Contact the Firm
The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against QuidelOrtho Corporation ("QuidelOrtho" or "the Company") for violations of 10(b) and 20(a) of the Securities...

at 07:00
YS Biopharma Announces Unaudited Financial Results for the First Nine Months of Fiscal Year 2024
YS Biopharma Co., Ltd. ("YS Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and...

at 06:40
Class Action Filed Against QuidelOrtho Corporation f/k/a Quidel Corporation (QDEL) - June 11, 2024 Deadline to Join - Contact The Gross Law Firm
The Gross Law Firm issues the following notice to shareholders of QuidelOrtho Corporation f/k/a Quidel Corporation . Shareholders who...

at 06:00
Vaccinologists Keith Klugman and Shabir Madhi Awarded Sabin's Prestigious Gold Medal; Infectious Diseases Epidemiologist Nicole Basta Receives Rising Star Award
The Sabin Vaccine Institute yesterday presented the Albert B. Sabin Gold Medal to physician-researchers Keith Paul Klugman and Shabir Ahmed Madhi, and its Rising Star award to infectious diseases epidemiologist Nicole Elaine Basta at a ceremony in...

at 05:45
Nextdoor Holdings, Inc. f/k/a Khosla Ventures Acquisition Co. II Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before April 29, 2024 to Discuss Your Rights - KIND
The Gross Law Firm issues the following notice to shareholders of Nextdoor Holdings, Inc. f/k/a Khosla Ventures Acquisition Co. II ....

at 01:20
Biophytis Announces Ratio Change Under its American Depositary Receipt ("ADR") Program
Biophytis SA (Euronext Growth Paris:ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotechnology company specialized in thedevelopment oftherapeutics for age-related diseases, today annouces that it will change the ratio...

More news about Covid-19 virus...


News published on and distributed by: